Novus Therapeutics Reports Second Quarter 2019 Financial Results
For the three-months ended June 30, 2019, the company reported a net loss of $4.1 million.
Read MoreSelect Page
Posted by Invest In Weed | Aug 13, 2019
For the three-months ended June 30, 2019, the company reported a net loss of $4.1 million.
Read MorePosted by Invest In Weed | Jul 29, 2019
GTI is a national cannabis consumer packaged goods company and retailer, is dedicated to providing dignified access to cannabis while giving back to the communities in which they serve.
Read MorePosted by Invest In Weed | Jun 10, 2019
A Phase 1 Safety Study of Repeated Doses of Intranasal OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adults: A Potential Treatment for Otitis Media.
Read MorePosted by Invest In Weed | May 31, 2019
The warrants will have an exercise price of $1.30 per share, will be immediately exercisable and will expire five years from the date of issuance.
Read MorePosted by Invest In Weed | May 30, 2019
The update reviews current performance, anticipated future organic performance, insight into the company’s merger and acquisition (M&A) strategy.
Read MoreGet stock alerts, news & related alerts straight to your inbox!